T3 Companies, LLC

Position in DFTX — Definium Therapeutics, Inc.

CIK 2052441 NEW YORK, NY

Back to DFTX Full portfolio

Position in DFTX

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$0

New position

Shares Held

0

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2026

1 quarter on record

Derivatives in DFTX

reported options exposure · as of Jun 30, 2026

CallValue

$823,200

CallShares

17,500

PutValue

$540,960

PutShares

11,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

T3 Companies, LLC holds $2,660,789 across 5 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	7,815	$1,041,426
2	IFRX	InflaRx N.V.	331,014	$741,471
3	YARW	Yarrow Bioscience, Inc.	18,900	$615,195
4	CLDX	Celldex Therapeutics, Inc.	6,000	$223,260
5	SANA	Sana Biotechnology, Inc.	11,300	$39,437

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$823,200	17,500	—	Call	Sole	2026-07-27
2026-06-30	$540,960	11,500	—	Put	Sole	2026-07-27
No filing history on record for this holder in this stock.

T3 Companies, LLC

Position in DFTX

Derivatives in DFTX

Position in Biotechnology

All Filings in DFTX